Select Page

Michael Patterson

Toronto, May 27-29, 2024

We are look forward to hosting our 9th Conference and Expo just minutes from the airport at the Delta by Marriott Toronto Airport Convention Centre. Don't miss out on Canada's largest collection of growers, retailers and brands.

Michael Patterson

Edmonton, AB, September 29 - Oct. 1, 2024

We are look forward to hosting our 10th Conference and Expo downtown at the Edmonton Convention Centre. Don't miss out on Canada's largest collection of growers, retailers and brands.

Previous Speaking Engagements at Grow Up:
2021 Niagara Falls

Michael Patterson

Michael Patterson is the CEO of US Cannabis Pharmaceutical Research and Development LLC (US Cannabis), a privately-held developmental consulting firm which was established in 2014 with the mission of moving society forward through legalized cannabis.  US Cannabis develops the legal cannabis/hemp/cbd markets globally across all platforms (education, cultivation, production, dispensing, research and development, management operations and compliance, and physician services).

US Cannabis currently works with national, state, and local governments, sovereign nations, and public/private companies in all aspects of the cannabis/hemp/CBD industry throughout the United States and Internationally.

Mr. Patterson is President and Executive board member of MGMC-Pharma Group, an international medical cannabis pharmaceutical corporation with EU-GMP cannabis cultivation, production, and export/distribution licenses in 6 East African Countries (Lesotho, Tanzania, Malawi, Democratic Republic of Congo, Zimbabwe, Uganda) and offices in Australia, Italy, and the United States. MGMC Global | The African Medical Cannabis Company | Maseru (mgmc-group.com)

Michael is an internationally recognized speaker, subject matter expert in the global cannabis/hemp/cbd industry, and published author. Michael is a member of the Scientific Advisory Board for Akers Bioscience, a NASDAQ listed biotechnology company, International Cannabis/Hemp/CBD SME for Gerson Lehrman Group (GLG)- an International Investment Consulting Group, Advisory Board member for Integrated Compliance Solutions (icslv.com), and Editorial Board Member for AJEM-American Journal of Endocannabinoid Medicine (the world’s first peer-reviewed printed scientific journal dedicated to the study of endocannabinoid science and medicine) (ajendomed.com)

Mr. Patterson is also a board member for the Medical Cannabis Society, Tourette’s Syndrome Awareness Foundation, Cannabis/Hemp/CBD industry writer for Florida MD Magazine, Orlando Medical News, licensed Occupational Therapist and Nursing Home Administrator in 4 states (NJ, NC, VA, FL), and podcast host for “The Cannabis Report with Michael Patterson”